Virax Biolabs Group Limited (NASDAQ:VRAX) IPO

Virax Biolabs Group Limited

IPO

Priced at US$5.00 a share on Jul 20, 2022.

Price
US$5.00 a share
Shares offered
3,294,784 ordinary shares · 1,350,000 from the company and 1,944,784 from selling shareholders
Offering size
US$6.8 million
Listing
VRAX on the Nasdaq Capital Market
Underwriters
BOUSTEAD SECURITIES, LLC, VALUABLE CAPITAL LIMITED · In the order on the cover
Shares delivered
On or about Jul 25, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceDec 27, 2021
Filed publiclyMar 18, 2022
Amended 6 timesNewest Jun 27, 2022
Shares registered with an exchangeJun 30, 2022
Declared effective by the SECJun 30, 2022
Final prospectus, with the priceJul 21, 2022

From the cover of the final prospectus (424B4) filed Jul 21, 2022